Payer reap rewards of new drug spending over the long haul

March 1, 2002

Washington, D.C. - Health plans and payers will save money inthe long run if they spend more on newer medicines that can keep patientshealthy and lower healthcare expenditures overall. That's the conclusionof several economists at a recent briefing hosted by the American EnterpriseInstitute and the National Pharmaceutical Council.